249420.KS
Ildong Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 12,570.00
−1.72%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- —
- Revenue estimate
- KRW 153.7B
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- KRW 401
- EPS estimate
- —
- Revenue actual
- KRW 143.7B
- Revenue estimate
- KRW 143.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | — | KRW 401 | — | KRW 143.7B |
| May 13, 2026 | — | KRW 261 | — | KRW 137.8B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026